J7210 Inj, afstyla, 1 i.u.

Injection, factor viii, (antihemophilic factor, recombinant), (afstyla), 1 i.u.

• Medicare coverage: Carrier judgment
• Status: active (July 2026 file)
• MUE: max 22000 units per day (practitioner), rationale: Clinical: CMS Workgroup